GoodRx Holdings, Inc. (GDRX) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY25 Revenue Guidance

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q1 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $202.97 million versus the consensus estimate of $202.59 million.

GUIDANCE:

GoodRx Holdings, Inc. sees FY2025 revenue of $810-840 million, versus the consensus of $823.3 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.

You May Also Be Interested In

• Goldman: 'Our top picks include XYZ, KLAR, AFRM, and CHYM'
• Helen of Troy (HELE) Tops Q1 EPS by 22c, Beats on Revenue; Offers FY Guidance
• PepsiCo (PEP) Misses Q2 EPS by 1c, Beats on Revenue